ListedSMEMAHALIFE

Mahamaya Lifesciences IPO

Mahamaya Lifesciences IPO is a sme IPO raising ₹70 Cr at ₹108 – ₹114 a share. It listed on 18 Nov 2025 and trades at ₹165 today, +44.8% against its issue price of ₹114. It was subscribed 0.00× in total.

114
Issue price
165
Price now
+44.8%
Since issue price
18 Nov 2025
Listed on
0.00×Subscribed (final) · all exchanges

No bids yet

populated partly populated we hold nothing here — the tab says why

Source documents

What the issuer and the exchanges published. Everything else on this tab is read out of these.

Read-out of the prospectus

A severity-ranked risk register with every item cited to its page, plus litigation counts and rupee exposure and related-party dealings, are being built from the prospectus above. We read prospectuses for current and upcoming issues — historical issues will not gain these sections.